252 related articles for article (PubMed ID: 16475726)
21. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA.
Kano M; Shimada Y; Kaganoi J; Sakurai T; Li Z; Sato F; Watanabe G; Imamura M
Br J Cancer; 2000 Jan; 82(2):429-35. PubMed ID: 10646900
[TBL] [Abstract][Full Text] [Related]
22. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.
Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH
Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446
[TBL] [Abstract][Full Text] [Related]
23. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
Gazzaniga P; Gandini O; Giuliani L; Magnanti M; Gradilone A; Silvestri I; Gianni W; Gallucci M; Frati L; Aglianò AM
Clin Cancer Res; 2001 Mar; 7(3):577-83. PubMed ID: 11297251
[TBL] [Abstract][Full Text] [Related]
24. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation.
Nakamura T; Yasumura T; Hayashi K; Eguchi R; Ide H; Takasaki K; Kasajima T
Anticancer Res; 2000; 20(6C):4739-44. PubMed ID: 11205210
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients.
Lockett MA; Metcalf JS; Baron PL; O'Brien PH; Elliott BM; Robison JG; Cole DJ
Am Surg; 1998 Jun; 64(6):539-43; discussion 543-4. PubMed ID: 9619175
[TBL] [Abstract][Full Text] [Related]
27. [The detection of breast carcinoma micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction].
Zhang Q; Zhang Y; Gu X; Zhang M; Lin H; Qian H
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):430-2. PubMed ID: 11825433
[TBL] [Abstract][Full Text] [Related]
28. Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR.
Weber T; Lacroix J; Wörner S; Weckauf H; Winkler S; Hinz U; Schilling T; Frank-Raue K; Klar E; Knebel Doeberitz Mv Mv
Int J Cancer; 2003 Jan; 103(1):126-31. PubMed ID: 12455065
[TBL] [Abstract][Full Text] [Related]
29. [Value of diagnosing micrometastasis by nested RT-PCR in the peripheral blood and bone marrow in non-small cell lung cancer patients].
Zhou QH; Gong YL; Qin Y; Sun ZL; Sun ZF; Liu LX; Li L; Zhu W
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):62-5. PubMed ID: 12678991
[TBL] [Abstract][Full Text] [Related]
30. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
[TBL] [Abstract][Full Text] [Related]
31. Detection of circulating breast cancer cells with multiple-marker RT-PCR assay.
Hu XC; Chow LW
Anticancer Res; 2001; 21(1A):421-4. PubMed ID: 11299772
[TBL] [Abstract][Full Text] [Related]
32. Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.
Straub B; Müller M; Krause H; Goessl C; Schrader M; Heicappell R; Miller K
Oncol Rep; 2002; 9(3):545-9. PubMed ID: 11956625
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.
Tokunaga H; Lee DH; Kim IY; Wheeler TM; Lerner SP
Clin Cancer Res; 1999 Sep; 5(9):2520-5. PubMed ID: 10499628
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of RT-PCR in detection of axillary lymph node micrometastases from breast cancer].
Hao XB; Fu J; Qiu FH
Ai Zheng; 2003 Sep; 22(9):964-7. PubMed ID: 12969530
[TBL] [Abstract][Full Text] [Related]
35. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S
J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755
[TBL] [Abstract][Full Text] [Related]
36. [The current status of molecular detection of micrometastatic prostate cancer cells].
Deguchi T; Yang M; Yasuda M; Yokoi S; Nishino Y; Ehara H; Yamamoto N; Takahashi Y; Ishihara S
Hinyokika Kiyo; 1999 Aug; 45(8):565-9. PubMed ID: 10500964
[TBL] [Abstract][Full Text] [Related]
37. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
[TBL] [Abstract][Full Text] [Related]
38. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
Conzelmann M; Dieterle CP; Linnemann U; Berger MR
Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
[TBL] [Abstract][Full Text] [Related]
39. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder.
Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713
[TBL] [Abstract][Full Text] [Related]
40. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients.
Dingemans AM; Brakenhoff RH; Postmus PE; Giaccone G
Lab Invest; 1997 Sep; 77(3):213-20. PubMed ID: 9314945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
